Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
06/2006
06/15/2006US20060128976 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives
06/15/2006US20060127986 Genetically engineered Recombinant actinomycete cells for use as tool for the generation of heterologous proteins; contains nucleic acid molecules which comprise at least two modules that encode a modular polyketide synthase
06/14/2006EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF
06/14/2006EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor
06/14/2006CN1787994A 2,4,6-phenyl substituted cyclic ketoenols
06/14/2006CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity
06/14/2006CN1785989A Pyronone antibiotic its preparation method and application
06/14/2006CN1785988A Saflor yellow pigment rich in saflor yellow pigment B, its preparation method and use
06/08/2006WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors
06/08/2006WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
06/08/2006US20060122263 Central nervous system disorders;drug abuse; Parkinson's disease; antidepressants
06/08/2006US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
06/08/2006US20060122125 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
06/08/2006US20060122061 Arylphenyl-substituted cyclic ketoenols
06/08/2006US20060121530 combinatorial libraries; lipid solubility; solid phase synthesis
06/07/2006EP1666970A1 Compound for resist and radiation-sensitive composition
06/07/2006EP1664034A1 Substituted phenanthropyrans
06/07/2006EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors
06/07/2006EP1663934A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
06/07/2006EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
06/07/2006EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide
06/07/2006CN1781927A Mevalonic acid derivative
06/06/2006US7057077 Method for producing 2- (alkyl) cycloalkenone
06/06/2006US7056915 Compounds useful as reversible inhibitors of cysteine proteases
06/06/2006CA2258895C Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
06/06/2006CA2136903C Acetic acid derivatives
06/01/2006WO2006028523A3 Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
06/01/2006US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
05/2006
05/31/2006EP1661894A1 Process for production of 4-aminotetrahydropyrans and salts thereof with acids, intermediates for the process, and process for production thereof
05/31/2006EP1661885A1 Optically active alpha-aminooxyketone derivatives and process for production thereof
05/31/2006EP1660459A2 Arylsulfonamidobenzylic compounds
05/31/2006CN1780826A Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
05/30/2006US7053209 sustained release; may be diluted with solvent for administration
05/30/2006US7053109 Aminediols for the treatment of Alzheimer's disease
05/30/2006US7052886 Lactonizing mevinolinic acid to lovastatin in a totally aqueous medium
05/30/2006US7052885 Process for preparing heterocyclic (R)- and (S)-cyanohydrins
05/30/2006CA2413235C Processing method of lactonization in the preparation of statins
05/26/2006WO2006055472A2 Synthetic discodermolide analogs
05/26/2006WO2006054688A1 Process for producing tetrahydropyran-4-carboxylic acid compound
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006CN1777601A Nk-2 antagonist basic linear compounds and formulations containing them
05/24/2006CN1775774A Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
05/24/2006CN1257164C Aromatic amides, preparation method and application as medicines
05/23/2006US7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans
05/23/2006US7049271 Herbicides, acaricides, nematicides and insecticides
05/18/2006US20060106094 Synthetic discodermolide analogs
05/18/2006US20060101583 Heating dihydrofuran or dihydropyran derivative in presence of polyglycerol, water, and acid catalysis; deesterification, deamidation; distillation, filtration; aldol condensation; preserving products, for example cosmetic products, and surfaces
05/17/2006EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
05/17/2006CN1774421A Process for preparing 5-(4- fluorophenyl)- 1-[2r, 4r) -4-hydroxy-6-oxo- tetrahydro-pyran -2-yl) ethyl]-2 -isopropyl -4-phenyl- 1h-pyrrole-3 -carboxylic acid phenylamide
05/16/2006US7045535 Respiratory system disorders
05/16/2006US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
05/11/2006US20060100289 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
05/11/2006US20060100250 Biphenyl derivatives and their use as fungicides
05/11/2006US20060100106 Phenyl-substituted 2-enamino-ketonitriles
05/11/2006DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides
05/10/2006EP1265838B9 Novel fatty acid analogous
05/10/2006CN1771241A Process for preparing simvastatin having controlled ranges of simvastatin dimer content
05/10/2006CN1255398C Synthesis of cinvastatin
05/09/2006US7041845 Racemic mixture of a 5-hydroxy-3-ketoester compound is resolved into the two enantiomeric 5-hydroxy-3-ketoester A1 and A2 by preparative high performance liquid chromatography (HPLC) over a chiral carrier material
05/09/2006CA2233716C Methods of using discodermolide compounds
05/04/2006WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof
05/04/2006WO2006012227A3 Amido compounds and their use as pharmaceuticals
05/04/2006WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
05/04/2006US20060094902 Amino acid analogues
05/04/2006US20060094885 Novel process for the preparation of simvastatin
05/04/2006US20060094718 O-substituted hydroxyaryl derivatives
05/04/2006CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof
05/03/2006EP1652846A1 Polymerizable fluorinated compound, making method, polymer, resist composition and patterning process
05/03/2006EP1652844A2 Fluorinated monomer having cyclic structure, manufacturing method, polymer, photoresist composition and patterning process
05/03/2006CN1768049A 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
05/03/2006CN1254471C Substituted benzopyran anti-fungus compound
05/02/2006US7038064 Process for producing hydroxylactones
05/02/2006US7037524 Oral delivery of a botanical
04/2006
04/26/2006EP1649861A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound
04/26/2006EP1648866A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
04/26/2006EP1648856A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity
04/26/2006CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors
04/26/2006CN1764635A carboxylic acid compounds
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/20/2006US20060084817 Synthesis of aldonolactones, aldarolactones, and aldarodilactones using gas sparging
04/20/2006US20060084800 Synthesis of aldonolactones, aldarolactones, and aldarodilactones using azeotropic distillation
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/20/2006US20060083678 Radio-labeled compounds, compositions, and methods of making the same
04/19/2006EP1423363B1 Oral antidiabetic agents
04/19/2006EP1064275B2 Process for producing simvastatin and/or its derivatives
04/19/2006CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
04/19/2006CN1252061C Compound for inducing plant male sterility
04/19/2006CN1252055C Biphenyl carboxamides compounds
04/18/2006US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same
04/18/2006US7029707 Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
04/13/2006WO2006038606A1 Biaryl derivative
04/13/2006WO2006038594A1 N-type calcium channel inhibitor
04/13/2006WO2006038522A1 Tetrahydropyran compounds, liquid crystal compositions, and liquid crystal displays containing the compositions
04/13/2006US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/13/2006US20060079465 isolated from the Caenorhabditis elegance related to suppress of aging and stress
04/13/2006CA2574500A1 D-pyranosyl-substituted phenyls, medicaments containing said compounds, use thereof, and method for the production thereof
04/12/2006EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors
04/12/2006EP1643960A2 Arylsulfonamide derivatives
04/12/2006EP1358183B1 Cysteine protease inhibitors
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 129